421 related articles for article (PubMed ID: 33648582)
1. Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?
Riedel RN; Pérez-Pérez A; Sánchez-Margalet V; Varone CL; Maymó JL
Stem Cell Res Ther; 2021 Mar; 12(1):155. PubMed ID: 33648582
[TBL] [Abstract][Full Text] [Related]
2. Placental stem cells.
Antoniadou E; David AL
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():13-29. PubMed ID: 26547389
[TBL] [Abstract][Full Text] [Related]
3. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
Warrier S; Mohana Sundaram S; Varier L; Balasubramanian A
Placenta; 2022 Jan; 117():161-168. PubMed ID: 34915433
[TBL] [Abstract][Full Text] [Related]
4. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients.
Heidari F; Heidari R; Sabet MN; Hamidieh AA; Saltanatpour Z
Curr Stem Cell Res Ther; 2024; 19(5):644-652. PubMed ID: 37073149
[TBL] [Abstract][Full Text] [Related]
5. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
[TBL] [Abstract][Full Text] [Related]
6. Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis?
Manuelpillai U; Moodley Y; Borlongan CV; Parolini O
Placenta; 2011 Oct; 32 Suppl 4():S320-5. PubMed ID: 21570115
[TBL] [Abstract][Full Text] [Related]
7. The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.
Kim EY; Lee KB; Kim MK
BMB Rep; 2014 Mar; 47(3):135-40. PubMed ID: 24499672
[TBL] [Abstract][Full Text] [Related]
8. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy.
Bilic G; Zeisberger SM; Mallik AS; Zimmermann R; Zisch AH
Cell Transplant; 2008; 17(8):955-68. PubMed ID: 19069637
[TBL] [Abstract][Full Text] [Related]
9. A comparison of isolation and culture protocols for human amniotic mesenchymal stem cells.
Naeem A; Gupta N; Naeem U; Khan MJ; Elrayess MA; Cui W; Albanese C
Cell Cycle; 2022 Aug; 21(15):1543-1556. PubMed ID: 35412950
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
[TBL] [Abstract][Full Text] [Related]
11. Current Status and Future Prospects of Perinatal Stem Cells.
Torre P; Flores AI
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374593
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells.
Liu QW; Huang QM; Wu HY; Zuo GS; Gu HC; Deng KY; Xin HB
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478081
[TBL] [Abstract][Full Text] [Related]
13. Construction of tissue engineered skin with human amniotic mesenchymal stem cells and human amniotic epithelial cells.
Yu SC; Xu YY; Li Y; Xu B; Sun Q; Li F; Zhang XG
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4627-35. PubMed ID: 26698261
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
15. Amniotic MSCs reduce pulmonary fibrosis by hampering lung B-cell recruitment, retention, and maturation.
Cargnoni A; Romele P; Bonassi Signoroni P; Farigu S; Magatti M; Vertua E; Toschi I; Cesari V; Silini AR; Stefani FR; Parolini O
Stem Cells Transl Med; 2020 Sep; 9(9):1023-1035. PubMed ID: 32452646
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the proliferation, migration and angiogenic properties of human amniotic epithelial and mesenchymal stem cells and their effects on endothelial cells.
Wu Q; Fang T; Lang H; Chen M; Shi P; Pang X; Qi G
Int J Mol Med; 2017 Apr; 39(4):918-926. PubMed ID: 28259958
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope.
Pal D; Goyal J; Sharma U; Sharma A; Prashar S; Rathi G; Sharma B; Kumar U
Life Sci; 2021 Nov; 284():119901. PubMed ID: 34453941
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
[TBL] [Abstract][Full Text] [Related]
19. Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway.
Li JY; Ren KK; Zhang WJ; Xiao L; Wu HY; Liu QY; Ding T; Zhang XC; Nie WJ; Ke Y; Deng KY; Liu QW; Xin HB
Stem Cell Res Ther; 2019 Aug; 10(1):247. PubMed ID: 31399039
[TBL] [Abstract][Full Text] [Related]
20. Amniotic Mesenchymal Stromal Cells Exhibit Preferential Osteogenic and Chondrogenic Differentiation and Enhanced Matrix Production Compared With Adipose Mesenchymal Stromal Cells.
Topoluk N; Hawkins R; Tokish J; Mercuri J
Am J Sports Med; 2017 Sep; 45(11):2637-2646. PubMed ID: 28541092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
